LIQUISPEX(TM) LIQUID B2M CONTROL LEVEL 1 AND 2— 510(k) K946048
Substantially EquivalentClinical Controls, Inc.
FDA 510(k) clearance K946048 for LIQUISPEX(TM) LIQUID B2M CONTROL LEVEL 1 AND 2, Substantially Equivalent on 1995-02-10. Applicant: Clinical Controls, Inc.. Device class: 2.
Clearance details
- Applicant
- Clinical Controls, Inc.
- Product code
- Code JZG
- Device class
- Class 2
- Regulation
- 21 CFR 866.5630
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Grover Beach, CA, US
Recent devices under product code JZG
view all- K161297 — Beta-2-Microglobulin
- K122066 — HUMAN BETA-2 MICROGLOBULIN URINE KIT FOR USE ON THE SPAPLUS
- K110874 — ADVIA CHEMISTRY REAGENTS, AND ADVIA CHEMISTRY B2-MICROGLOBULIN CALIBRATOR
- K083289 — HUMAN BETA-2 MICROGLOBULIN KIT
- K083463 — DIMENSION VISTA BETA 2 MICROGLOBULIN, DIMENSION VISTA PROTEIN 1 CALIBRATOR, DIMENSION VISTA PROTEIN 1 CONTROL M
More clearances from Clinical Controls, Inc.
view all- K964278 — WHOLE BLOOD GLUCOSE CONTROL LEVEL 1,2,AND 3/WHOLE BLOOD GLUCOSE LINEARITY CONTROL-LEVEL1,2,3,4,5,AND 6
- K962432 — LIQUISPEX URINE (MICRO)ALBUMIN CONTROL
- K955690 — AQUEOUS ETHANOL/AMMONIA CONTROL LEVEL 1, 2, & 3
- K955691 — SERUM VOLATILES CONTROL LEVEL 1 & 2
- K946265 — FIBRINOGEN HIGH ABNORMAL CONTROL - LEVEL 3
Data sourced from openFDA. This site is unofficial and independent of the FDA.